Roberto W Dal Negro Selected Research

Roberto W Dal Negro Research Topics

Disease

18	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2005
11	Asthma (Bronchial Asthma) 11/2023 - 07/2005
4	Cough 01/2017 - 01/2008
3	Chronic Cough 01/2017 - 11/2014
2	Airway Obstruction (Choking) 01/2019 - 01/2008
1	Pneumonia (Pneumonitis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	COVID-19 01/2022
1	Emphysema 01/2021
1	Respiratory Sounds (Crackle) 01/2021
1	Human Influenza (Influenza) 01/2018
1	Cognitive Dysfunction 01/2015
1	Bronchitis 01/2008
1	Nasal Obstruction 12/2006
1	Aspirin-Induced Asthma 12/2006
1	Nasal Polyps (Nasal Polyp) 12/2006

Drug/Important Bio-Agent (IBA)

5	erdosteineIBA 01/2022 - 01/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2016
4	GoldIBA 01/2022 - 09/2012
4	AntioxidantsIBA 01/2019 - 01/2008
4	fluticasone furoate FDA Link 01/2018 - 01/2016
4	Beclomethasone (Beclometasone)FDA Link 01/2018 - 07/2005
4	vilanterolIBA 01/2018 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 07/2005
3	Formoterol Fumarate (Oxis)FDA Link 01/2018 - 01/2016
3	SteroidsIBA 01/2016 - 11/2014
2	Methacholine Chloride (Methacholine)FDA Link 11/2023 - 07/2005
2	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2019
2	Immunoglobulin E (IgE)IBA 01/2021 - 06/2011
2	AerosolsIBA 01/2017 - 01/2016
2	GasesIBA 01/2015 - 07/2012
2	Oxygen (Dioxygen)IBA 01/2015 - 07/2012
1	A-factor (Streptomyces)IBA 11/2023
1	Nebivolol FDA Link 01/2022
1	Therapeutic UsesIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	N 30IBA 01/2021
1	SmokeIBA 01/2021
1	TrypsinIBA 01/2021
1	2-chloroethyl methyl sulfideIBA 01/2019
1	8-epi-prostaglandin F2alphaIBA 12/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2016
1	sirioIBA 01/2015
1	AcidsIBA 11/2014
1	Hemoglobins (Hemoglobin)IBA 07/2012
1	AllergensIBA 06/2011
1	Monoclonal AntibodiesIBA 06/2011
1	anti-IgE antibodiesIBA 06/2011
1	Antitussive Agents (Antitussives)FDA Link 01/2008
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2008
1	Expectorants (Mucolytics)IBA 01/2008
1	acetylsalicylic acid lysinateIBA 12/2006
1	LeukotrienesIBA 12/2006
1	Arachidonic Acid (Vitamin F)IBA 12/2006
1	Leukotriene E4IBA 12/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2006
1	Lipoxygenase (Lipoxygenase-1)IBA 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	CytokinesIBA 03/2005
1	prednylidene (Pred)IBA 03/2005

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2014
4	Dry Powder Inhalers 01/2019 - 01/2015
3	Nebulizers and Vaporizers (Inhaler) 01/2019 - 01/2015
1	Duration of Therapy 01/2022
1	Precision Medicine 09/2016
1	Ambulatory Care (Outpatient Care) 01/2015